Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.5.0 replaces v3.4.3 in the Record History page.SummaryDifference0.1%

- Check17 days agoChange DetectedA new revision (v3.4.3) was added to the Record History, and the previous revision (v3.4.2) was removed.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and an older maintenance notice (v3.4.1) was removed; the changes pertain to site version updates and operating status notices. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check53 days agoChange DetectedAdded a site-wide notice regarding government funding and the NIH Clinical Center status, and updated the release to Revision: v3.4.1 while removing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check60 days agoChange DetectedThe page adds a 'Show glossary' option and updates the descriptions of color-coded highlights. Revision notes are updated to v3.4.0 and the No FEAR Act data wording is adjusted.SummaryDifference0.9%

- Check74 days agoChange DetectedNew historical revision label v3.3.4 has been added, replacing the previous v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.